Back
ProPhase Labs Stock Price Chart

Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
33
PRPH
ProPhase Labs
Last Price:
$0.31
Seasonality Move:
9.49%
7 Day Trial
ALL ACCESS PASS
$
7

Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PRPH is experiencing slight selling pressure.
ProPhase Labs Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.31 | Sell |
20-day SMA: | 0.32 | Sell |
50-day SMA: | 0.36 | Sell |
200-day SMA: | 1.29 | Sell |
8-day EMA: | 0.31 | Sell |
20-day EMA: | 0.32 | Sell |
50-day EMA: | 0.37 | Sell |
200-day EMA: | 1.41 | Sell |
ProPhase Labs Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.02 | Sell |
Relative Strength Index (14 RSI): | 45.6 | Sell |
Chaikin Money Flow: | -374777 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.28 - 0.34) | Sell |
Bollinger Bands (100): | (0.3 - 0.6) | Sell |
ProPhase Labs Technical Analysis
Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for ProPhase Labs Stock
Is ProPhase Labs Stock a Buy?
-
ProPhase Labs share price is 0.30 while PRPH 8-day simple moving average is 0.31, which is a Sell signal.
-
The stock price of PRPH is 0.30 while ProPhase Labs 20-day SMA is 0.32, which makes it a Sell.
-
ProPhase Labs 50-day simple moving average is 0.36 while PRPH share price is 0.30, making it a Sell technically.
-
PRPH stock price is 0.30 and ProPhase Labs 200-day simple moving average is 1.29, creating a Sell signal.
PRPH Technical Analysis vs Fundamental Analysis
Sell
33
ProPhase Labs (PRPH)
is a Sell
Is ProPhase Labs a Buy or a Sell?
-
ProPhase Labs stock is rated a SellThe current ProPhase Labs [PRPH] share price is $0.30. The Score for PRPH is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
ProPhase Labs Stock Info
Market Cap:
12.7M
Price in USD:
0.30
Share Volume:
1.1M
ProPhase Labs 52-Week Range
52-Week High:
5.45
52-Week Low:
0.22
Sell
33
ProPhase Labs (PRPH)
is a Sell
ProPhase Labs Share Price Forecast
-
What is the ProPhase Labs stock price today?The ProPhase Labs stock price is 0.30 USD today.
-
Will PRPH stock go up or go down?ProPhase Labs> share price is forecast to RISE/FALL based on technical indicators
-
Is ProPhase Labs overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ProPhase Labs is overvalued.
Is ProPhase Labs Stock a Buy?
-
ProPhase Labs share price is 0.30 while PRPH 8-day exponential moving average is 0.31, which is a Sell signal.
-
The stock price of PRPH is 0.30 while ProPhase Labs 20-day EMA is 0.32, which makes it a Sell.
-
ProPhase Labs 50-day exponential moving average is 0.37 while PRPH share price is 0.30, making it a Sell technically.
-
PRPH stock price is 0.30 and ProPhase Labs 200-day simple moving average is 1.41, creating a Sell signal.
Fundamental Analysis of ProPhase Labs
Is ProPhase Labs a good investment?
-
Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and a decrease next year of $0.00 per share.
Technical Analysis of ProPhase Labs
Should I short ProPhase Labs stock?
-
PRPH Moving Average Covergence Divergence (MACD) indicator is -0.02, suggesting ProPhase Labs is a Sell
-
ProPhase Labs Relative Strength Index (RSI) is 45.6, which suggest ProPhase Labs is oversold
-
The Bollinger Bands (25) for ProPhase Labs is (0.28 - 0.34), which suggest ProPhase Labs is a Sell
-
The Bollinger Bands (100) for ProPhase Labs is (0.3 - 0.6), which suggest ProPhase Labs is a Sell
* ProPhase Labs stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.